These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 19806907
21. Freezing-assisted intracellular drug delivery to multidrug resistant cancer cells. Teo KY, Han B. J Biomech Eng; 2009 Jul; 131(7):074513. PubMed ID: 19640149 [Abstract] [Full Text] [Related]
22. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW. J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [Abstract] [Full Text] [Related]
23. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay. Susa M, Choy E, Yang C, Schwab J, Mankin H, Hornicek F, Duan Z. J Biomol Screen; 2010 Mar; 15(3):287-96. PubMed ID: 20150589 [Abstract] [Full Text] [Related]
24. Nanotechnology applied to overcome tumor drug resistance. Gao Z, Zhang L, Sun Y. J Control Release; 2012 Aug 20; 162(1):45-55. PubMed ID: 22698943 [Abstract] [Full Text] [Related]
25. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells. Xu D, Fang L, Zhu Q, Hu Y, He Q, Yang B. Pharmazie; 2008 Jul 20; 63(7):528-33. PubMed ID: 18717489 [Abstract] [Full Text] [Related]
26. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells. Yadav S, van Vlerken LE, Little SR, Amiji MM. Cancer Chemother Pharmacol; 2009 Mar 20; 63(4):711-22. PubMed ID: 18618115 [Abstract] [Full Text] [Related]
27. Can flavonoids from honey alter multidrug resistance? Jaganathan SK. Med Hypotheses; 2011 Apr 20; 76(4):535-7. PubMed ID: 21247706 [Abstract] [Full Text] [Related]
28. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells. Ji BS, He L. J Pharm Pharmacol; 2007 Jul 20; 59(7):1011-5. PubMed ID: 17637197 [Abstract] [Full Text] [Related]
29. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Malam Y, Loizidou M, Seifalian AM. Trends Pharmacol Sci; 2009 Nov 20; 30(11):592-9. PubMed ID: 19837467 [Abstract] [Full Text] [Related]
30. Nanoparticle approaches to combating drug resistance. Moon JH, Moxley JW, Zhang P, Cui H. Future Med Chem; 2015 Aug 20; 7(12):1503-10. PubMed ID: 26334205 [Abstract] [Full Text] [Related]
31. [Growth inhibition and multidrug resistance-reversing effect of tanshinone I A on human breast cancer cell with estrogen receptor negative]. Jing J, Zheng H, Wang J, Lin P, Zhang J, Xiong ZJ, Wu YY, Ren JJ, Yang HL, Wang XJ. Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun 20; 38(3):391-5. PubMed ID: 17593814 [Abstract] [Full Text] [Related]
33. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Fu L, Liang Y, Deng L, Ding Y, Chen L, Ye Y, Yang X, Pan Q. Cancer Chemother Pharmacol; 2004 Apr 20; 53(4):349-56. PubMed ID: 14666379 [Abstract] [Full Text] [Related]
35. Reversal of cancer multidrug resistance by green tea polyphenols. Mei Y, Qian F, Wei D, Liu J. J Pharm Pharmacol; 2004 Oct 20; 56(10):1307-14. PubMed ID: 15482646 [Abstract] [Full Text] [Related]
36. A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence. Sawicka M, Kalinowska M, Skierski J, Lewandowski W. J Pharm Pharmacol; 2004 Sep 20; 56(9):1067-81. PubMed ID: 15324475 [Abstract] [Full Text] [Related]
40. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells. Bartolini G, Orlandi M, Papi A, Ammar K, Guerra F, Ferreri AM, Rocchi P. In Vivo; 2006 Sep 20; 20(6A):729-33. PubMed ID: 17203756 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]